4.7 Review

The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma

期刊

JOURNAL OF CLINICAL MEDICINE
卷 12, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/jcm12113732

关键词

renal cell carcinoma; kidney cancer; lymph node dissection

向作者/读者索取更多资源

The role of lymph node dissection (LND) in the management of nonmetastatic localized renal cell carcinoma (RCC) is still controversial. While some studies have suggested a potential benefit, most studies do not indicate a clear advantage, and there is a lack of standardized indications and templates for LND.
Purpose: To explore the current role of lymph node dissection (LND) in the management of nonmetastatic localized renal cell carcinoma (RCC). Background: There is currently no proven benefit of LND in the setting of RCC, and its role remains controversial because of conflicting evidence. Patients who may benefit from LND are those at greatest risk of nodal disease, but the tools used to predict nodal involvement are limited due to unpredictable retroperitoneal lymphatics. The indications, templates, and extent of LND are also not standardized, adding to the ambiguity of current guidelines surrounding its use. Evidence Acquisition: A PubMed search of the literature from January 2017 to December 2022 was conducted using the search terms renal cell carcinoma or renal cancer in combination with lymph node dissection or lymphadenectomy. Case studies and editorials were excluded, whereas studies investigating the therapeutic effect of LND were classified as either demonstrating a benefit or no benefit. References of the studies and review articles were also searched for notable studies and findings that were outside the five-year literature search. The studies in this review were restricted to the English language. Results: Only a number of studies in recent years have found an association between the extent of LND and increased survival. Most studies do not indicate an associated benefit, and some even suggest a negative effect on survival. Most of these studies are retrospective. Conclusion: The therapeutic value of LND in RCC is still unclear, and although prospective data are needed, its declining rates and emerging new therapies make this unlikely. A better understanding of renal lymphatics and improved detection of nodal disease may help determine the role of LND in nonmetastatic localized RCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据